Works matching AU Brandt, Simon


Results: 92
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Bioisosteric analogs of MDMA: Improving the pharmacological profile?

    Published in:
    Journal of Neurochemistry, 2024, v. 168, n. 9, p. 2022, doi. 10.1111/jnc.16149
    By:
    • Alberto‐Silva, Ana Sofia;
    • Hemmer, Selina;
    • Bock, Hailey A.;
    • da Silva, Leticia Alves;
    • Scott, Kenneth R.;
    • Kastner, Nina;
    • Bhatt, Manan;
    • Niello, Marco;
    • Jäntsch, Kathrin;
    • Kudlacek, Oliver;
    • Bossi, Elena;
    • Stockner, Thomas;
    • Meyer, Markus R.;
    • McCorvy, John D.;
    • Brandt, Simon D.;
    • Kavanagh, Pierce;
    • Sitte, Harald H.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study.

    Published in:
    Drug Testing & Analysis, 2024, v. 16, n. 9, p. 1002, doi. 10.1002/dta.3622
    By:
    • Angerer, Verena;
    • Schmid, Yasmin;
    • Franz, Florian;
    • Gnann, Heike;
    • Speer, Jan Manuel;
    • Gnann, Anke;
    • Helmecke, Stephan;
    • Buchwald, Armin;
    • Brandt, Simon D.;
    • Passie, Torsten;
    • Liechti, Matthias E.;
    • Auwärter, Volker
    Publication type:
    Article
    32
    33
    34

    In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin‐8‐yl 4‐methyl‐3‐(morpholine‐4‐sulfonyl)benzoate [QMMSB]) and (quinolin‐8‐yl 4‐methyl‐3‐((propan‐2‐yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing

    Published in:
    Drug Testing & Analysis, 2023, v. 15, n. 2, p. 181, doi. 10.1002/dta.3385
    By:
    • Richter, Matthias J.;
    • Wagmann, Lea;
    • Kavanagh, Pierce V.;
    • Brandt, Simon D.;
    • Meyer, Markus R.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4‐methylphenmetrazine (4‐MPM), with differentiation from its ortho‐ and meta‐ positional isomers.

    Published in:
    Drug Testing & Analysis, 2018, v. 10, n. 9, p. 1404, doi. 10.1002/dta.2396
    By:
    • McLaughlin, Gavin;
    • Baumann, Michael H.;
    • Kavanagh, Pierce V.;
    • Morris, Noreen;
    • Power, John D.;
    • Dowling, Geraldine;
    • Twamley, Brendan;
    • O'Brien, John;
    • Hessman, Gary;
    • Westphal, Folker;
    • Walther, Donna;
    • Brandt, Simon D.
    Publication type:
    Article
    49

    An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer‐supported reagents

    Published in:
    Drug Testing & Analysis, 2018, v. 10, n. 7, p. 1198, doi. 10.1002/dta.2383
    By:
    • Dowling, Geraldine;
    • Kavanagh, Pierce V.;
    • Eckhardt, Hans‐Georg;
    • Twamley, Brendan;
    • Hessman, Gary;
    • McLaughlin, Gavin;
    • O'Brien, John;
    • Brandt, Simon D.
    Publication type:
    Article
    50